The joint action “Health4EUkids” of the European project EU4Health, co-financed by the European Union and HaDEA, is framed in the field of health promotion and prevention of non-communicable diseases. This action, led in Cantabria by the Health Economics Group, the Clinical and Translational Research Group in Digestive Diseases, the Pediatrics Service of the Marqués de […]
IDIVAL organizes two days in which students from different fields and levels will face health challenges through innovation The “Santander i-Days 2024” event is set to inspire students from all academic disciplines in the field of healthcare innovation. This year, the event will be held on two dates: on October 29 online, and on November […]
IDIVAL Advances in One-Step Diagnosis for Determining MASH and Liver Fibrosis in High-Risk Populations The United European Gastroenterology Journal has just published an innovative study in the field of hepatology. The research, conducted by the Clinical and Translational Research Groupin Digestive Diesases at IDIVAL, led by Dr. Paula Iruzubieta and Dr. Javier Crespo, in collaboration […]
A global study that determines the frequency and type of genetic variants that cause the disease Researchers from the neurodegenerative diseases group of IDIVAL and the Neurology Service of HUMV, led by Dr. Jon Infante, have participated in an international study carried out in 16 countries and on 12,580 patients with Parkinson’s disease. Although the […]
The Medical Oncology Service of the Marqués de Valdecilla University Hospital participates in numerous European initiatives within the EU4Health program. Since 2021, following the launch of the European Plan to Combat Cancer, the European Union (EU) is investing heavily in the fight against cancer. This plan sets out a new EU approach to cancer prevention, […]
Published in June 2022, the article has been recognized by Wiley as one of the ten most cited during 2022 and 2023 in the journal PAIN Practice The research article titled “Sensitization symptoms are associated with psychological and cognitive variables in COVID-19 survivors exhibiting post-COVID pain,” carried out by researchers of the IDIVAL nursing group, […]
Cantabria’s largest biomedical research project, a pioneer in Spain, makes steady progress towards its goal of 50,000 participants. The ambitious biomedical research project Cohorte Cantabria has today reached 40,000 participants, approaching its goal of 50,000 volunteers. The great reception of this initiative by the Cantabrian population reflects the commitment of our citizens to improve public […]
Two new publications show results on the effectiveness of inhibitors of janus kinases (iJAK) in giant cell arteritis (GCA) and on the effectiveness of the antibody tocilizumab for aortitis in GCA. Researchers from the Immunopathology Group of IDIVAL, led by Dr. Javier Loricera García and Dr. Ricardo Blanco Alonso, have carried out two studies to […]
The meeting of the IDIVAL Nursing research group highlighted the progress and next steps in the pilots it is leading in Cantabria on health literacy, integrated care pathways and self-management of patients with these diseases. On July 2, the Nursing research group of the Marqués de Valdecilla Health Research Institute (IDIVAL), led by Dr. Carmen […]
The Valdecilla Clinical Trials Unit and the Research Support Unit of the Marqués de Valdecilla Research Institute (IDIVAL) have highlighted the importance of specialised talent in supporting the execution of clinical trials. This announcement comes in light of recent findings published in a comprehensive review on challenges and solutions in the field of clinical trials. […]
